
Ron Finklestien
Analyst Bullish On Phathom Pharmaceuticals
Expert Analyst Sees Bright Future for Phathom Pharmaceuticals With Voquezna Launch
Needham analyst Joseph Stringer reiterated a Buy rating on Phathom Pharmaceuticals, Inc.PHAT, raising the price target to $26 from $23. “PHAT is our top ...
Geopolitical Tensions Drive Crude Oil Price Increase
Oil prices lifted by Middle East tensions, outweighing demand concerns for now
SlavkoSereda/iStock via Getty Images As the rollercoaster ride of the global economy continues, crude oil futures have ascended this week. Contributing to this climb ...
Exciting Developments Propel Dermata Therapeutics
Exciting Developments Propel Dermata Therapeutics
Dermata Therapeutics Inc DRMA stock was trading higher Friday after the company shared some exciting news. The firm announced the issuance of a new patent ...
Bearish Report Predicts Chegg’s Demise
Bearish Report Predicts Chegg’s Demise
Chegg, Inc. CHGG shares have plummeted nearly 60% over the past year, and a recently released report by Edwin Dorsey’s “The Bear Cave” is ...
Challenges Hit NuScale Power as Layoffs Cut 40% of Workforce
Challenges Hit NuScale Power as Layoffs Cut 40% of Workforce
vchal/iStock via Getty Images NuScale Power (NYSE:SMR) saw a steep decline of 8.4% in Friday’s trading, marking its lowest close in six weeks. This ...














